Deloitte Access Economics

The healthcare sector faces ongoing pricing and cost pressures, driving a focus on operating performance within an evolving regulatory and risk environment. Economics tools, such as burden of disease modelling and pharmaceutical and health technology assessments, inform decisions that lead to more affordable and outcomes-based healthcare — ultimately enhancing patient care, accountability, compliance and stakeholder value. Economic modelling, analysis and advisory services in healthcare are combined to assist clients to quantify their impact on and contribution to the healthcare economy and provide a basis for assessing policy settings to understand future business impacts and support decision making.

Our services

Combining economic skills with deep health sector expertise, we provide professional advice and solutions across the full range of sector issues. Our rigorous and highly regarded quantitative and qualitative analysis is supported by proprietary and specialist models and analytical techniques refined over many years. Our highly qualified health economists and human services practitioners have a strong reputation for objectivity and integrity. Our service offerings include:

• Pharmaceuticals and health technology assessment: including pharmacoeconomic analysis, market access (regulation and reimbursement) strategy, and outcomes research and health technology assessments for pharmaceutical, biotechnology and government client
• Program evaluation: including program logics, evaluation frameworks, and mixed methods (qualitative and quantitative) techniques using cross-sectional and longitudinal designs.
• Financial improvement and services planning: including demand and capacity modelling, operational improvement, feasibility assessments, activity-based costing and value based pricing informing health service design, and planning for healthcare providers and funders, including hospital operators.
• Impact analysis: including cost-benefit, cost-effectiveness, and cost-of-illness (disease burden) analysis for a broad range of health sector clients across public, private and not-for-profit organisations to quantify the impact of health conditions, social determinants of health, service/workforce models and technologies on the economy.
• Healthcare policy: including population health, acute, primary and emergency services, aged and disability care, mental health, child and family services, justice and Indigenous issues, ehealth, and research investments.

Thoughtware